Allele-specific network reveals combinatorial interaction that transcends small effects in psoriasis GWAS
Sharlee Climer1, Alan R Templeton2, Weixiong Zhang3
1Department of Computer Science and Engineering, Washington University, St. Louis, Missouri, United States of America.
Plos Computational Biology
|September 19, 2014
Summary
BlocBuster identifies complex disease genetic patterns by analyzing genome-wide networks. This approach reveals combinatorial genetic associations, significantly advancing our understanding of diseases like psoriasis.
Area of Science:
- Genetics
- Systems Biology
- Computational Biology
Background:
- Complex diseases are influenced by numerous genetic factors, but a significant portion of heritability remains unexplained.
- Discovering combinatorial genetic interactions is challenging due to computational complexity and genetic heterogeneity.
Purpose of the Study:
- To introduce BlocBuster, a novel systems-level computational approach for identifying genome-wide, allele-specific genetic interaction networks.
- To address the "missing heritability" by efficiently detecting combinatorial genetic associations in heterogeneous data.
Main Methods:
- BlocBuster constructs genome-wide, allele-specific networks using a customized correlation measure for single nucleotide polymorphisms.
- It segregates homogenous combinations of genetic factors and tests their association with phenotypes.
- The method incorporates rigorous, unbiased validation procedures and captures genetic heterogeneity.
Main Results:
- Application to psoriasis revealed a significant combinatorial genetic pattern (odds ratio 3.64, p-value 5.01×10⁻¹⁶).
- This finding was successfully replicated in independent datasets, demonstrating the robustness of BlocBuster.
- The method effectively identified combinatorial associations in heterogeneous genome-wide data.
Conclusions:
- BlocBuster offers a powerful approach to uncover complex genetic architectures underlying diseases.
- The method enhances disease susceptibility prediction and deepens the understanding of disease pathogenesis.
- BlocBuster overcomes limitations of analyzing individual genetic markers by revealing the impact of their interactions.
Related Concept Videos
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Pharmacogenomics: Identification of New Drug Targets
113
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113

